Skip to search formSkip to main contentSkip to account menu

123I-IBZM

Known as: Iodine I 123 Iodobenzamide 
A radiopharmaceutical containing the dopamine D2/D3 receptor agonist iodobenzamide (IBZM) labeled with the radionuclide iodine I 123 with dopamine… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Dopamine D2 receptor SPECT with 123I-IBZM: evaluation of collimator and post-filtering when using model-based compensation—a Monte Carlo study
In 123I-IBZM brain SPECT, the main interest is the activity uptake in the striatum relative to the background, and semi… 
Review
2007
Review
2007
Diagnostic imaging of dopamine receptors in pituitary adenomas.
Dopamine D2 receptor scintigraphy of pituitary adenomas is feasible by single-photon emission computed tomography using (123)I-S… 
2005
2005
SPECT con 123I-IBZM: utilidad en el diagnóstico diferencial de parkinsonismos degenerativos y establecimiento de un método de cuantificación
Resumen Objetivos : Valorar la utilidad de la SPECT con 123 I-Iolopride ( 123 I-IBZM) en el diagnostico diferencial de pacientes… 
2005
2005
Dopamine D2 receptor binding is reduced in Wilson's disease: Correlation of neurological deficits with striatal123I-Iodobenzamide binding
SummaryTo visualise and quantify dopamine D2 receptor binding in the corpus striatum of patients with neurological Wilson's… 
1997
1997
Registration of dynamic dopamine D2 receptor images using principal component analysis
Abstract.This paper describes a novel technique for registering a dynamic sequence of single-photon emission tomography (SPET… 
1994
1994
123I-IBZM SPECT: Reconstruction Methodology and Results in Parkinsonism and Dystonia
Summary In 58 patients with Parkinsonism or dystonia striatal dopamine D2 receptors were investigated using 123l-iodobenzamide… 
1994
1994
[Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders].
The aim of this SPECT study was to determine whether there is a correlation between rCBF (99mTc-HMPAO) and D2 receptor binding… 
1993
1993
[Brain SPECT with 123I-labelled iodobenzamide (IBZM): aspects of semiquantitative evaluation].
The striatal dopamine-D2-receptor uptake of 123I-IBZM in 32 patients (18 without and 14 under therapy with typical neuroleptics… 
1993
1993
Validation of quantitative brain dopamine D2 receptor imaging with a conventional single-head SPET camera
Phantom measurements were performed with a conventional single-head single-photon emission tomography (SPET) camera in order to… 
1992
1992
[The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
An alteration of the dopaminergic nigrostriatal system is believed to be the main pathogenetic factor of Parkinson's disease (PD… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)